Assessment of Partially Deoxygenated Deoxynojirimycin Derivatives as Glucosylceramide Synthase Inhibitors

[Image: see text] Glucosylceramide synthase (GCS) is an approved drug target for the treatment of Gaucher disease and is considered as a valid target for combating other human pathologies, including type 2 diabetes. The clinical drug N-butyldeoxynojirimycin (Zavesca) is thought to inhibit through mi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van den Berg, Richard J. B. H. N., Wennekes, Tom, Ghisaidoobe, Amar, Donker-Koopman, Wilma E., Strijland, Anneke, Boot, Rolf G., van der Marel, Gijsbert A., Aerts, Johannes M. F. G., Overkleeft, Herman S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2011
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018170/
https://ncbi.nlm.nih.gov/pubmed/24900342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml200050s
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados